Koffi N'da Konan

Title: Koffi N'da Konan: Innovator in Allergen-Free Peanut Technology

Introduction

Koffi N'da Konan is a notable inventor based in Huntsville, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of allergen-free transgenic peanut seeds. His innovative work aims to address the challenges posed by peanut allergies, which affect millions of individuals worldwide.

Latest Patents

Koffi N'da Konan holds 3 patents related to the down-regulation and silencing of allergen genes in transgenic peanut seeds. His latest patent describes a method for producing allergen-free transgenic peanut seeds through recombinant techniques. This involves transforming peanut plants with multiple copies of allergen genes or their fragments to suppress gene expression and allergen protein production. The patent also details the use of peanut allergen antisense genes introduced into the peanut genome, which can be in the form of antisense fragments, sense fragments, or combinations of both. The transgenes are regulated by the 35S promoter or the promoter of the Ara h2 gene, facilitating the production of various RNA types to inhibit allergen protein production.

Career Highlights

Throughout his career, Koffi N'da Konan has focused on advancing agricultural biotechnology. His research has led to the isolation and sequencing of a full-length genomic clone for the allergen Ara h2, which is crucial for understanding and mitigating peanut allergies. The findings from his patents have the potential to revolutionize the peanut industry by providing safer options for consumers.

Collaborations

Koffi has collaborated with notable colleagues such as Hortense W Dodo and Charles Joel Arntzen. Their combined expertise has contributed to the success of his research and the development of innovative solutions in the field of allergen-free food production.

Conclusion

Koffi N'da Konan's work in developing allergen-free transgenic peanut seeds represents a significant advancement in biotechnology. His innovative approaches have the potential to improve the lives of those affected by peanut allergies and contribute to safer food options in the market.